These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10932343)

  • 1. [Bronchodilation test in patients with stable COPD].
    Heredia Budó JL; Rodríguez-Carballeira M
    Arch Bronconeumol; 2000 Jun; 36(6):334-43. PubMed ID: 10932343
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bronchodilator testing in patients with stable COPD].
    Díez Herranz A
    Arch Bronconeumol; 2001 Mar; 37(3):154-5. PubMed ID: 11333545
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship between airway resistance FEV 1.0 and viscous work of breathing in patients with chronic obstructive lung disease before and after bronchodilation.
    Quanjer PH; Hilvering C; Tammeling GJ
    Bull Physiopathol Respir (Nancy); 1971; 7(3):539-54. PubMed ID: 5119274
    [No Abstract]   [Full Text] [Related]  

  • 4. [Greater decrease in lung function in COPD during continuous rather than during symptom-oriented bronchodilator medication].
    Geijer R
    Ned Tijdschr Geneeskd; 1993 Mar; 137(10):517. PubMed ID: 8455744
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD.
    Cazzola M; Matera MG; Di Perna E; Califano C; D'Amato M; Mazzarella G
    Respir Med; 1999 Dec; 93(12):909-11. PubMed ID: 10653054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Greater deterioration of lung function in COPD during continuous than during symptom-oriented bronchodilator treatment].
    Maesen BL; Maesen FP
    Ned Tijdschr Geneeskd; 1993 Jun; 137(23):1158-60. PubMed ID: 8316313
    [No Abstract]   [Full Text] [Related]  

  • 7. Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease.
    Cazzola M; Vinciguerra A; Di Perna F; Matera MG
    Respir Med; 1998 Aug; 92(8):1012-6. PubMed ID: 9893768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis, diagnosis and therapy of COPD].
    Ullmer E; Solèr M; Hamm H; Perruchoud AP
    Pneumologie; 2000 Mar; 54(3):123-32. PubMed ID: 10783652
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute effects of bronchodilators on lung function and dyspnea in COPD patients].
    Taube C; Jörres RA; Magnussen H
    Pneumologie; 2000 Jun; 54(6):252-5. PubMed ID: 10934896
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
    Cazzola M; Calderaro F; Califano C; Di Pema F; Vinciguerra A; Donner CF; Matera MG
    Eur J Clin Pharmacol; 1999 Jan; 54(11):829-33. PubMed ID: 10027655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing obstructive lung disease. Why is differentiating COPD from asthma important?
    Subramanian D; Guntupalli KK
    Postgrad Med; 1994 Jun; 95(8):69-70, 75-8, 83-5. PubMed ID: 8202424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.
    Johnson M; Rennard S
    Chest; 2001 Jul; 120(1):258-70. PubMed ID: 11451847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil Aerolizer) with salbutamol (Ventodisk).
    Benhamou D; Cuvelier A; Muir JF; Leclerc V; Le Gros V; Kottakis J; Bourdeix I
    Respir Med; 2001 Oct; 95(10):817-21. PubMed ID: 11601748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of the effects of an inhaled bronchodilator on gas distribution and ventilatory efficiency in patients with COPD.
    Cutillo A; Watanabe S; Bigler AH; Perondi R; Turiel M; Renzetti AD
    Chest; 1980 Feb; 77(2 Suppl):293-6. PubMed ID: 7357914
    [No Abstract]   [Full Text] [Related]  

  • 15. Utility of transfer factor to detect different bronchodilator responses in patients with chronic obstructive pulmonary disease.
    Izquierdo-Alonso JL; Sánchez-Hernández I; Fernández Francés J; Castelao Naval J; Carrillo Arias F; Gallardo Carrasco J
    Respiration; 1998; 65(4):282-8. PubMed ID: 9730794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Body plethysmographic investigations with the new bronchodilator NAB365 (author's transl)].
    Kaik G
    MMW Munch Med Wochenschr; 1975 May; 117(22):959-60. PubMed ID: 807812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchodilator therapy of COPD. A reanalysis suggests new roles and new concerns.
    Deffebach ME
    Chest; 1996 Jul; 110(1):5-6. PubMed ID: 8681663
    [No Abstract]   [Full Text] [Related]  

  • 18. Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of flow pattern.
    Mouloudi E; Prinianakis G; Kondili E; Georgopoulos D
    Eur Respir J; 2000 Aug; 16(2):263-8. PubMed ID: 10968501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of pulmonary neuronal M(2) muscarinic receptors in stable chronic obstructive pulmonary disease.
    On LS; Boonyongsunchai P; Webb S; Davies L; Calverley PM; Costello RW
    Am J Respir Crit Care Med; 2001 May; 163(6):1320-5. PubMed ID: 11371395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled therapy in COPD: what are the benefits?
    Postma DS
    Respir Med; 1991 Nov; 85(6):447-9. PubMed ID: 1775669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.